Key result
Physicians evaluate the perceived benefit-risk balance of fibrinolytic therapy in STEMI.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Physician perceptions of fibrinolytic benefit-risk in STEMI highlight decision variability; leaves open standardization of risk assessment tools.
Pineda, Alexandre; Savary, Dominique; Vromant, Amélie; Lapostolle, Frédéric Author Information
No takes yet. Share an insight, caveat, or question.
Pineda et al. (2023) studied this question. Fibrinolytic therapy for ST-elevation myocardial infarction was evaluated by physicians to assess its perceived benefit-risk balance.
Synapse has enriched 10 related papers. Consider them for comparative context: